✦ LIBER ✦

Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection

✍ Scribed by Antonij Slavcev; Jiri Lácha; Eva Honsová; Helena Sajdlová; Alena Lodererová; Stefan Vitko; Jelena Skibová; Ilja Striz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Panel reactive HLA antibodies, soluble C

✍ Elizabeth M.F.L. Domingues; Teresa Matuck; Miguel L. Graciano; Edison Souza; Suz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Soluble CD30 and Hepatocyte growth facto

✍ Yelena Pavlova; Ondrej Viklicky; Janka Slatinska; Marcela Bürgelova; Caner Süsal 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 443 KB

Pre-transplant and post-transplant solub

✍ Mohsen Nafar; Farhat Farrokhi; Mohammad Vaezi; Amir-Ebrahim Entezari; Fatemeh Po 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 189 KB

Post-Transplant Anti-HLA Class II Antibo

✍ É. F. Campos; H. Tedesco-Silva; P. G. Machado; M. Franco; J. O. Medina-Pestana; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

8-P: Soluble CD30 as an immune risk fact

✍ Ronald H. Kerman; Stanislaw M. Stepkowski; Richard M. Knight; Charles T. Van Bur 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 41 KB

38-OR: Soluble CD30 and HLA antibodies h

✍ Leanne L. Langan; Tiffany L. Hughes; Larry P. Park; Grant Luxton; Campbell S. Wi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 33 KB